Breitfeld P P, Simmons C F, Strous G J, Geuze H J, Schwartz A L
Int Rev Cytol. 1985;97:47-95. doi: 10.1016/s0074-7696(08)62348-7.
Substantial information about the ASGP-R has accumulated in the 10 years following the initial studies of this receptor by Ashwell and Morell. Many of its biochemical properties, its structure, and its orientation within the plasma membrane are now known. The pathways of ASGP ligand and receptor, with the CURL organelle being a central component, are summarized in Fig. 18. The major pathway of the ligand through the cell, beginning with binding at the cell surface and ending with degradation in lysosomes, has been investigated in detail. Recently, alternate routes of the ligand such as the ligand recycling pathway have been observed. With regard to the itinerary of the receptor, there is now biochemical, kinetic, and morphological evidence to support receptor recycling. The new concept of CURL as an important intracellular organelle has originated from studies of ASGP-R recycling. Its importance in the dissociation and segregation of ligand and receptor as well as in receptor recycling is now evident. In addition, there has been a concurrent investigation of other receptor systems that participate in receptor-mediated endocytosis, providing parallels and contrasts to the ASGP-R of hepatocytes. Many critical issues still exist in the cell biology of the ASGP-R. What are the structural requirements of the receptor for ligand binding and subsequent endocytosis of the receptor-ligand complex? Very little is known about the interactions between the receptor and the lipid bilayer in which it resides. How does the receptor move laterally in the plasma membrane? Are there proteins or glycolipids closely associated with the ASGP-R and, if so, what is their function? What is the mechanism that causes receptor clustering into coated pits? Although the existence of a pathway for ligand recycling has been demonstrated, there are still many issues to be addressed. What signals a particular ligand molecule for recycling? Is it a stochastic process? What is the function of this route of ligand movement? How are the various ligand pathways coordinated and regulated? In addition, there are many unanswered questions regarding the receptor pathway. How does CURL mediate the sorting of ASGP-R from ligand? How are receptors with different destinations (e.g., ASGP-R and IgA receptor) sorted in CURL? What is the mechanism of ASGP-R degradation and how is it regulated? Finally, how does the Golgi function in the ASGP system and what is the relationship between the Golgi and CURL? Future investigation of these issues will require further observations with existing techniques as well as new approaches.(ABSTRACT TRUNCATED AT 400 WORDS)
在阿什韦尔和莫雷尔对该受体进行初步研究后的10年里,积累了大量有关去唾液酸糖蛋白受体(ASGP-R)的信息。现在已知其许多生化特性、结构以及在质膜中的取向。以CURL细胞器为核心组成部分的ASGP配体和受体途径总结于图18中。已经详细研究了配体通过细胞的主要途径,该途径始于在细胞表面结合,终于在溶酶体中降解。最近,观察到了配体的替代途径,如配体循环途径。关于受体的行程,现在有生化、动力学和形态学证据支持受体循环。CURL作为一种重要的细胞内细胞器的新概念源于对ASGP-R循环的研究。其在配体与受体的解离和分离以及受体循环中的重要性现在很明显。此外,同时对参与受体介导的内吞作用的其他受体系统进行了研究,与肝细胞的ASGP-R形成了对比。在ASGP-R的细胞生物学中仍然存在许多关键问题。受体与配体结合以及随后受体 - 配体复合物内吞作用的结构要求是什么?对于受体与其所在的脂质双层之间的相互作用知之甚少。受体如何在质膜中横向移动?是否有与ASGP-R紧密相关的蛋白质或糖脂,如果有,它们的功能是什么?导致受体聚集到有被小窝中的机制是什么?尽管已经证明存在配体循环途径,但仍有许多问题有待解决。是什么信号促使特定的配体分子进行循环?这是一个随机过程吗?这种配体移动途径的功能是什么?各种配体途径是如何协调和调节的?此外。关于受体途径还有许多未解答的问题。CURL如何介导ASGP-R与配体的分选?具有不同目的地的受体(例如,ASGP-R和IgA受体)如何在CURL中进行分选?ASGP-R降解的机制是什么以及如何调节?最后,高尔基体在ASGP系统中如何发挥作用以及高尔基体与CURL之间的关系是什么?对这些问题的未来研究将需要利用现有技术以及新方法进行进一步观察。(摘要截选至400字)